The President Donald Trump administration's request for Novavax Inc. to conduct new clinical trials for its COVID-19 vaccine ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

Novavax faces uncertainty as FDA requests a new clinical trial for its COVID-19 vaccine, the last protein-based option in the ...

Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...

Zoetis, Inc. ZTS is slated to report its first-quarter 2025 earnings on May 6, 2025, before the opening bell. The Zacks ...

Novavax shows financial improvement but faces vaccine challenges. Read why I rated NVAX stock as 'Hold' and what risks and ...

After a 20% cut to the FDA’s workforce, biotechs and pharmas are bracing for delays. But the impacts won’t be consistent.

A summary of current health news, including the disbanding of a U.S. Justice Department unit focusing on food and drug safety ...

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.